Proteolytic action of thrombin is required for electrical activity-dependent synapse reduction - PubMed (original) (raw)

Proteolytic action of thrombin is required for electrical activity-dependent synapse reduction

Y Liu et al. Proc Natl Acad Sci U S A. 1994.

Abstract

Molecular mechanisms of activity-dependent synapse reduction were studied in an in vitro mammalian neuromuscular preparation. Synapse reduction in this model is activity-dependent and is substantially reduced by the broad-spectrum protease inhibitor, leupeptin, suggesting the role of activity-dependent proteolytic action in the process. Our present experiments show that a potent and specific thrombin inhibitor, hirudin, at nanomolar concentration completely blocked the activity-dependent synapse reduction. Furthermore, a naturally occurring serine protease inhibitor, protease nexin I (PNI), which closely colocalizes with acetylcholine receptors at the neuromuscular junction, inhibited the synapse reduction at the same low concentration. In contrast, neither cystatin, a cysteine protease inhibitor, nor aprotinin, a serine protease inhibitor that does not inhibit thrombin, blocked the synapse reduction. Similarly, neither of the inhibitors of the calcium-activated proteases calpain I and II prevented the reduction of synapses. These results strongly suggest that serine proteolytic action by thrombin or thrombin-like molecules is required for synapse reduction in our in vitro model of the mammalian neuromuscular junction.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Prog Brain Res. 1983;58:359-64 - PubMed
    1. Proc Natl Acad Sci U S A. 1977 Oct;74(10):4516-9 - PubMed
    1. J Neurosci Res. 1994 Jan;37(1):108-15 - PubMed
    1. Trends Neurosci. 1988 Dec;11(12):541-4 - PubMed
    1. J Neurosci. 1993 Feb;13(2):834-55 - PubMed

MeSH terms

Substances

LinkOut - more resources